Posts

Kirkland advises Vista Equity Partners in $3.5 billion acquisition

Kirkland & Ellis represents Vista Equity Partners, a global investment firm focused on enterprise software, data and technology-enabled businesses, which announced today a definitive agreement to acquire Pluralsight, Inc. (NASDAQ: PS), the technology workforce development company. Under the terms of the agreement, Vista, in partnership with its institutional co-investors including Partners Group, will acquire all outstanding shares of Pluralsight common stock in an all-cash transaction valued at approximately $3.5 billion.

The transaction is expected to close in the first half of 2021, subject to customary closing conditions, including approval by Pluralsight shareholders and receipt of regulatory approvals. Upon completion of the transaction, Pluralsight will become a privately held company and shares of Pluralsight common stock will no longer be listed on any public market.

The Kirkland team was led by transactional partners David Klein, Daniel Wolf, Stuart Casillas, Nathan Davis and James Beach, along with transactional partner Jean Lee and associates Nick Howe and Katherine Schloss Ackerman, debt finance partners Sonali Jindal and Douglas Tedeschi, tax partners David Kung and Heidi Yuen, executive compensation partner Mike Krasnovsky and associate Laura Gallo, and capital markets partner Robert Goedert.

Click here to read full press release.

Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ

Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.

4D, who are leading the development of live biotherapeutic products, are believed to be the first UK biotech to make the move to NASDAQ via the acquisition of a SPAC, breaking new ground for UK listed biotech’s. The Company will also maintain its current listing on AIM.

With 4D acquiring the SPAC in order to inherit its listing on NASDAQ, they are able to by-pass the usual nine month lead-in time foreign issuers have to contend with when seeking a direct listing on NASDAQ.

The Pinsent Masons team was led by Charles Waddell and Sunjay Malhotra with assistance from Julian Stanier, Amy Moore and Nathalie Goetsches; US securities advice was provided by Roberta Markovina and Beatrice Kelly; Eloise Walker, Jamie Robson and Daniel Place assisted on UK tax matters; and Fleur Benns and James Sullivan-Tailyour provided assistance with regards to 4D’s share option plans.

Commenting on the transaction, lead partner at Pinsent Masons Charles Waddell said: “We have enjoyed working with 4D for a number of years, they are at the cutting edge of live biotherapeutic products and this transaction is an important step in their future development and access to key to international markets.

Given the number of European biotech’s that covet a move to NASDAQ, and notwithstanding the complex financing structures of SPACs, this deal highlights that there is an alternative route to the US markets. It is therefore unlikely to be the last biotech we see looking at SPACs to access the deep pool of sophisticated investors in the United States.”

The Schall Law Firm investigating claims on behalf of investors

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Alder BioPharmaceuticals, Inc. (“Alder” or “the Company”) (NASDAQ: ALDR) for potential breaches of fiduciary duty on the part of its directors in connection with the pending sale of the Company to H. Lundbeck A/S.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at https://schallfirm.com/, or by email at [email protected].

The Schall Law Firm represents investors around the world and specialises in securities class action lawsuits and shareholder rights litigation.

MicroStrategy® Wins a 2018 Industry Excellence Award

MicroStrategy® Incorporated (Nasdaq: MSTR), a leading worldwide provider of enterprise analytics and mobility software, today announced that Dresner Advisory Services has honored MicroStrategy with a 2018 Technology Leader for Business Intelligence award for its strong position in the 2018 Wisdom of Crowds® Business Intelligence (BI) report.

The Dresner Advisory Services Industry Excellence Awards go to brands that were ranked as leaders in two user-rating models included in the Wisdom of Crowds series of global Dresner research reports. The reports are based on data collected from a large base of end users in the BI and analytics industry and provide a broad and detailed assessment of each market, including current product usage, key buying drivers, technology priorities, and future intentions, as well as performance ratings of all relevant vendors.

“We congratulate MicroStrategy for receiving top marks from its customer base,” said Howard Dresner, founder and chief research officer at Dresner Advisory Services. “The unique value of our research is in its end user perspective of the market, both in adoption trends and intentions, and the ability to provide an unfiltered assessment of industry suppliers.”

The MicroStrategy platform provides the capabilities organizations need to build and deploy modern analytics and mobility applications that transform and accelerate business decisions. By putting answers in everyone’s hands, regardless of enterprise role, function, or skill level, the MicroStrategy platform helps organizations become a more Intelligent Enterprise™.

“The recognition from industry leader Dresner Advisory Services marks another milestone in our mission of making every enterprise a more Intelligent Enterprise,” said Michael J. Saylor, CEO, MicroStrategy Incorporated. “With our award-winning enterprise analytics and mobility platform, organizations around the world can get the answers they need, delivered where they need them, to make effective decisions for competitive advantage, driving their digital transformation initiatives and planning today for tomorrow’s challenges.”

This award is the latest in a line of increasing industry recognition for MicroStrategy, which was top ranked in the 2018 Wisdom of Crowds Location Intelligence Market Study and received a Dresner Advisory Services 2017 Technology Innovation Award for embedded BI and big data analytics. Start a free trial of MicroStrategy Desktop™ today.

About Dresner Advisory Services

Dresner Advisory Services was formed by Howard Dresner, an independent analyst, author, lecturer, and business adviser. Dresner Advisory Services, LLC focuses on creating and sharing thought leadership for Business Intelligence (BI), information management, performance management and related areas.

About MicroStrategy Incorporated

MicroStrategy (Nasdaq: MSTR) is a worldwide leader in enterprise analytics and mobility software. A pioneer in the BI and analytics space, MicroStrategy delivers innovative software that empowers people to make better decisions and transform the way they do business. We provide our enterprise customers with world-class software and expert services so they can deploy unique intelligence applications. To learn more, visit MicroStrategy online, and follow us on LinkedIn, Twitter and Facebook.

MicroStrategy, MicroStrategy Desktop, and Intelligent Enterprise are either trademarks or registered trademarks of MicroStrategy Incorporated in the United States and certain other countries. Other product and company names mentioned herein may be the trademarks of their respective owners.

Tilray® Announces International Advisory Board

Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis production and distribution, today announced the formation of its International Advisory Board, an esteemed group of business and government leaders who will provide guidance to Tilrays executive team and Board of Directors as the company pursues its aggressive global growth strategy.

We are honored to welcome this impressive group of distinguished leaders to the Tilray team, says Brendan Kennedy, Tilray CEO. As we pioneer the future of our industry around the world, the experts on our International Advisory Board will advise us on our rapidly expanding global business.

Inaugural members of Tilrays International Advisory Board include:

  • Governor Howard Dean is a former Democratic National Committee (DNC) Chairman, presidential candidate, six-term Governor of Vermont, and physician. Gov. Dean is also the founder of Democracy for America, a lecturer at Yale University and a strategic consultant for the global law firm Dentons.
  • Michael Steele made history when he was elected Lieutenant Governor of Maryland in 2003, as the first African American elected to statewide office; and again, with his subsequent chairmanship of the Republican National Committee (RNC). Under Mr. Steeles leadership the RNC broke fundraising records and led Republicans to win 63 House seats in 2010, the biggest pick-up since 1938. Mr. Steele is an accomplished author and media commentator.
  • The Honourable Lloyd Axworthy P.C., C.C., O.M., is the chair of the World Refugee Council and one of Canadas leading voices on global migration and refugee protection. Throughout his 27-year political career, he served as Canadas Minister of Foreign Affairs and Minister of Employment and Immigration, among other postings.
  • Joschka Fischer served as Foreign Minister and Vice Chancellor of the Federal Republic of Germany. He is a member of the Board of Trustees of the International Crisis Group and a member of the Executive Board of the European Council on Foreign Relations. Mr. Fischer also currently serves as Managing Partner of Joschka Fischer & Company, a global strategy firm, where he advises clients on issues relating to Germany and the European Union.
  • Jaime Gama is the longest-serving Portuguese Minister of Foreign Affairs. Over a distinguished career in public policy, Mr. Gama served as Minister of Foreign Affairs, Minister of Home Affairs, Minister of Defense, and Minister of State. He was a member of the Government in 2001 when Portugal approved its decriminalization and harm reduction drug policy. He was elected Member of Parliament and served as the Speaker of the Parliament. Mr. Gama serves as the chairman of a bank and of a private foundation.
  • The Honourable Alexander John Gosse Downer, AC, was the longest-serving Minister for Foreign Affairs in Australia in history, holding his position for ten years. He also served has High Commissioner to the United Kingdom. Mr. Downer was a diplomat in the Department of Foreign Affairs, serving in the Australian Mission to the European Union, the Australian Representation to the North Atlantic Treaty Organization (NATO) and at Australian embassies in Belgium and Luxembourg.
  • Rt Hon Sir Donald McKinnon, ONZ, GCVO, was New Zealands longest serving Minister of Foreign Affairs and Trade and held the portfolios of Disarmament and Arms Control, Veterans Affairs, War Pensions, and Pacific Island Affairs. Mr. McKinnon served as Deputy Prime Minister, Leader of the House and was appointed a member of Her Majestys Privy Council. He was nominated for the Nobel Peace Prize for his work in initiating and overseeing the ceasefire between Bougainvilleans and the Papua New Guinea Government in 1997.
  • Mar­a Lorena Gutirrez Botero served as Minister of Commerce, Industry and Tourism, as well as Ambassador of Colombia to Germany, as a member of President Juan Manuel Santos government. Ms. Gutirrez has served as a member of numerous boards of directors of international organizations and universities, such as the European Foundation for Management Development, the Sumaq Alliance, the Latin American Council of Administration Schools, the Business Association for Latin American Studies and the Quality Corporation of Colombia.
  • James OBrien served two U.S. administrations as Special Presidential Envoy. Mr. OBrien has been Senior Advisor to the U.S. Secretary of State and served as the Principal Deputy Director of Policy Planning at the State Department. Mr. OBrien currently serves as Vice Chair of Albright Stonebridge Group (ASG) and heads up the firms practice in Europe.
  • Dr. Lorna Marsden is a former Canadian Senator from Ontario who was appointed to the position by former Prime Minister Pierre Trudeau. She served in the Senate for eight and a half years, where she was a member of the Standing Committee on National Finance and chairwoman of the Standing Committee on Social Affairs, Science and Technology. Dr. Marsden also served as President and Vice-Chancellor of York University and President and Vice-Chancellor of Wilfrid Laurier University in Waterloo, Ontario.

About Tilray, Inc.

Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids is currently serving tens of thousands of patients in twelve countries spanning five continents.

Cautionary Note regarding Forward-looking Statements:

This press release contains forward-looking statements, which may be identified by the use of words such as, may, would, could, will, likely, expect, anticipate, believe, intend, plan, forecast, project, estimate, outlook and other similar expressions, including statements related to Tilrays global strategy and the International Advisory Board. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of managements experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including assumptions in respect of current and future market conditions. Actual results, performance or achievement could differ materially from that expressed in, or implied by, any forward-looking statements in this press release, and, accordingly, you should not place undue reliance on any such forward-looking statements and they are not guarantees of future results. Forward-looking statements involve significant risks, assumptions, uncertainties and other factors that may cause actual future results or anticipated events to differ materially from those expressed or implied in any forward-looking statements. Please see the heading Risk Factors in Tilrays Quarterly Report on Form 10-Q for the quarter ended June 30, 2018 and the risks discussed in Tilrays other filings with the Securities and Exchange Commission for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. Tilray does not undertake to update any forward-looking statements that are included herein, except in accordance with applicable securities laws.

NRC Health Awards Annual Scholarship to UNL Students

NRC Health is pleased to announce Conrad Shiu and Nathan Netz as recipients of the 2018 Rising Stars Scholarship. In partnership with the University of Nebraska-Lincoln (UNL), the annual scholarship celebrates, rewards, and encourages students with an interest in business development, marketing, and entrepreneurship. Each recipient received $2,000 to be applied toward their tuition and fees during the spring 2019 semester. The scholarship program began in 2011.

Conrad and Nathan will be recognised and awarded the scholarship at a dinner hosted by NRC Health on Wednesday, December 5, at Misty’s Steakhouse in downtown Lincoln. NRC leadership will attend the event along with the recipient’s guests. Conrad and Nathan’s names will be displayed on the Rising Stars Scholarship plaque located in the Sales Center for Excellence at the College of Business (CoB).

Conrad is a senior Accounting and Marketing major and a member of the CoB’s Business Honors Academy and Center for Sales Excellence. He is a Founder of Builer Advisory, the world’s first workplace consultancy run by students.

Nathan is a junior Finance and Marketing major and a member of the CoB’s Center for Sales Excellence. He has held several leadership positions in Farmhouse Fraternity and aspires to transform his family farm by delving into a new agricultural market.

NRC Health actively pursues students from UNL to join the organisation as interns. For more information on internship and career opportunities, contact [email protected]

About NRC Health

For 37 years, NRC Health (NASDAQ:NRC) has been committed to achieving human understanding and bringing healthcare organisations closer to their customers than ever before by illuminating and improving the key moments that define an experience and build trust. Guided by their uniquely empathic heritage, proprietary methods, skilled associates, and holistic approach, NRC Health helps its customers design experiences that exceed expectations, inspire loyalty, and improve well-being among patients, residents, physicians, nurses, and staff.

For more information, write to [email protected], or visit www.nrchealth.com.